MicroRNAs in vascular biology and vascular disease

Journal of Cardiovascular Translational Research

Volumn 3, Issue 3, 2010, Pages 235-240

  Zhang, Chunxiang ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Gene regulation; MicroRNAs; Vascular biology; Vascular disease

Indexed keywords

ALPHA ACTIN; CALPONIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DICER; DIPEPTIDYL CARBOXYPEPTIDASE; FIBROBLAST GROWTH FACTOR; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 5; MESSENGER RNA; MICRORNA; MYOCARDIN; MYOSIN HEAVY CHAIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR ELK 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CAROTID ARTERY INJURY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSLATION REGULATION; VASCULAR DISEASE; ANIMAL; BLOOD VESSEL; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BLOOD VESSELS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR DISEASES;

EID: 77955628346     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-010-9164-z     Document Type: Review

References (47)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature, 431, 350-355.
2. Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5), 843-854.
3. Wightman, B., Ha, I., & Ruvkun, G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 75(5), 855-862.
4. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001). Identification of novel genes coding for small expressed RNAs. Science, 294(5543), 853-858.
5. Friedman, J. M., & Jones, P. A. (2008). MicroRNAs: Critical mediators of differentiation, development and disease. Swiss Medical Weekly, 139(33-34), 466-472.
6. Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nature Genetics, 37(7), 766-770.
7. Chen, K., & Rajewsky, N. (2007). The evolution of gene regulation by transcription factors and microRNAs. Nature Reviews Genetics, 8, 93-103.
8. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
9. Zhang, C. (2008). MicroRNomics: A newly emerging approach for disease biology. Physiological Genomics, 33(2), 139-147.
10. De Paepe, B. (2009). Anti-angiogenic agents and cancer: Current insights and future perspectives. Recent Patents on Anti-cancer Drug Discovery, 4(2), 180-185.
11. Di Stefano, R., Felice, F., & Balbarini, A. (2009). Angiogenesis as risk factor for plaque vulnerability. Current Pharmaceutical Design, 15(10), 1095-1106.
12. Smart, N., Dubé, K. N., & Riley, P. R. (2009). Coronary vessel development and insight towards neovascular therapy. International Journal of Experimental Pathology, 90(3), 262-283.
13. Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circulation Research, 100(11), 1579-1588.
14. Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009). A necessary role of miR-222 and miR-221 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research, 104(4), 476-487.
15. Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D., Lu, Q., et al. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research, 105, 158-166.
16. Poliseno, L., Tuccoli, A., Mariani, L., Evangelista, M., Citti, L., Woods, K., et al. (2006). MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 108, 3068-3071.
17. Kuehbacher, A., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research, 101(1), 59-68.
18. Suárez, Y., Fernández-Hernando, C., Pober, J. S., & Sessa, W. C. (2007). Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circulation Research, 100 (8), 1164-1173.
19. Fish, J. E., Santoro, M. M., Morton, S. U., Yu, S., Yeh, R. F., Wythe, J. D., et al. (2008). miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell, 15(2), 272-284.
20. van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M., Roeten, M. K., van Oeveren-Rietdijk, A. M., et al. (2009). Antagomirmediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of Cellular and Molecular Medicine, 13(8A), 1577-1585.
21. Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., et al. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics, 38(9), 1060-1065.
22. Chen, Y., & Gorski, D. H. (2008). Regulation of angiogenesis through a microRNA(miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood, 111(3), 1217-1226.
23. Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., et al. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry, 283(23), 15878-15883.
24. Lee, D. Y., Deng, Z., Wang, C. H., & Yang, B. B. (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proceedings of the National Academy of Sciences of the United States of America, 104(51), 20350-20355.
25. Würdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., et al. (2008). miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell, 14(5), 382-393.
26. Li, Y., Song, Y. H., Li, F., Yang, T., Lu, Y. W., & Geng, Y. J. (2009). MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochemical and Biophysical Research Communications, 381(1), 81-83.
27. Minami, Y., Satoh, M., Maesawa, C., Takahashi, Y., Tabuchi, T., Itoh, T., et al. (2009). Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. European Journal of Clinical Investigation, 39(5), 359-367.
28. Wang, C. H., Lee, D. Y., Deng, Z., Jeyapalan, Z., Lee, S. C., Kahai, S., et al. (2008). MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE, 3(6), e2420.
29. Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 324(5935), 1710-1713.
30. Chan, L. S., Yue, P. Y., Mak, N. K., & Wong, R. N. (2009). Role of MicroRNA-214 in ginsenoside-Rg1-induced angiogenesis. European Journal of Pharmaceutical Sciences, 38(4), 370-377.
31. Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., et al. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460(7256), 705- 710.
32. Zhang, C. (2009). MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease. Cell Cycle, 8(21), 3469-3473.
33. Elia, L., Quintavalle, M., Zhang, J., Contu, R., Cossu, L., Latronico, M. V., et al. (2009). The knockout of miR-143 and - 145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease. Cell Death and Differentiation, 16(12), 1590-1598.
34. Lin, Y., Liu, X., Cheng, Y., Yang, J., Huo, Y., & Zhang, C. (2009). Involvement of microRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. Journal of Biological Chemistry, 284(12), 7903-7913.
35. Davis, B. N., Hilyard, A. C., Nguyen, P. H., Lagna, G., & Hata, A. (2009). Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. Journal of Biological Chemistry, 284(6), 3728-3738.
36. Boettger, T., Beetz, N., Kostin, S., Schneider, J., Krüger, M., Hein, L., et al. (2009). Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on theMir143/145 gene cluster. Journal of Clinical Investigation, 119(9), 2634-2647.
37. Xin, M., Small, E. M., Sutherland, L. B., Qi, X., McAnally, J., Plato, C. F., et al. (2009). MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes & Development, 23(18), 2166-2178.
38. Pushparaj, P. N., Aarthi, J. J., Kumar, S. D., & Manikandan, J. (2008). RNAi and RNAa-The yin and yang of RNAome. Bioinformation, 2(6), 235-237.
39. Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., et al. (2008). The endothelial-specific microRNA miR- 126 governs vascular integrity and angiogenesis. Developmental Cell, 15(2), 261-271.
40. Kuhnert, F., Mancuso, M. R., Hampton, J., Stankunas, K., Asano, T., Chen, C. Z., et al. (2008). Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development, 135(24), 3989-3993.
41. Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T., & Lowenstein, C. J. (2008). MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. The Proceedings of the National Academy of Sciences, 105(5), 1516-1521.
42. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signaling, 2(100), ra81.
43. Mishra, P. J., Mishra, P. J., Banerjee, D., & Bertino, J. R. (2008). MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle, 7(7), 853-858.
44. Wang, M., Ye, Y., Qian, H., Song, Z., Jia, X., Zhang, Z., et al. (2010). Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis. Journal of Human Genetics, 55(1), 13-17.
45. Sethupathy, P., & Collins, F. S. (2008). MicroRNA target site polymorphisms and human disease. Trends in Genetics, 24(10), 489-497.
46. Yang, Z., & Kaye, D. M. (2009). Mechanistic insights into the link between a polymorphism of the 3′UTR of the SLC7A1 gene and hypertension. Human Mutation, 30(3), 328-333.
47. Fluiter, K., Mook, O. R., & Baas, F. (2009). The therapeutic potential of LNA-modified siRNAs: Reduction of off-target effects by chemical modification of the siRNA sequence. Methods in Molecular Biology, 487, 189-203.